As with all products, the MHRA will keep its safety under close review. The Medicines and Healthcare products Regulatory ...

Hundreds of thousands of doses of unlicensed medicine have been seized as part of a regulator's "largest ever" crackdown on ...

Dawn raids in four counties across the West Midlands and the Northwest of England this morning (29 April) dismantle major ...

Bristol Myers Squibb (BMS) has announced that an injectable version of its cancer immunotherapy Opdivo (nivolumab) has been ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a reminder to sufferers of the importance of using ...

Thousands of drugs including opioid painkillers and anti-anxiety medication were seized in raids along with around £100,000 ...

Nivolumab is a monoclonal antibody that works by binding to a protein called PD-1 on a type of immune cell called T-cell.

Symbiosis Pharmaceutical Services passed its recent audit conducted by the UK’s Medicines and Healthcare products Regulatory ...

In dawn raids in four counties across the West Midlands and Northwest of England this morning, 12 suspects were arrested in ...

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...